Acute fulminant hepatitis after treatment with rabeprazole and terbinafine: is rabeprazole the culprit?

Arch Intern Med. 2002 Feb 11;162(3):360-1. doi: 10.1001/archinte.162.3.360.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Acute Disease
  • Benzimidazoles / adverse effects*
  • Benzimidazoles / therapeutic use
  • Biopsy, Needle
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / pathology*
  • Drug Interactions
  • Follow-Up Studies
  • Humans
  • Naphthalenes / adverse effects*
  • Naphthalenes / therapeutic use
  • Omeprazole / analogs & derivatives
  • Rabeprazole
  • Risk Assessment
  • Severity of Illness Index
  • Terbinafine

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Benzimidazoles
  • Naphthalenes
  • Rabeprazole
  • Terbinafine
  • Omeprazole